Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

Trypanosoma cruzi (T. cruzi) is the causative agent of Chagas disease (CD), which mostly affects underprivileged populations in South and Central America. The current standard of care for this disease are the two empirically discovered drugs benznidazole and nifurtimox. They show low efficacy, diffi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteur: Petrick, Joy Kristin
Andere auteurs: Klebe, Gerhard (Prof. Dr.) (Thesis begeleider)
Formaat: Dissertation
Taal:Engels
Gepubliceerd in: Philipps-Universität Marburg 2019
Onderwerpen:
Pharmakologie, Therapeutik
mevalonate
farnesyl pyrophosphate
kissing bug
Isoprenoid
FPPS
Fragment-basierte Wirkstoffforschung
FDPS
Chagas disease
Chagas
fragment based drug discovery
Protein-Kristallograph
protein cry
isoprenoid
Vernachlässigte Krankheit
Farnesylpyroposphate-Synthase
neglected disease
Pharmacology & therapeutics, prescription drugs
Online toegang:PDF Full text
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

PDF Full text

Exemplaargegevens van
Plaatsingsnummer: urn:nbn:de:hebis:04-z2019-05018
Publicatiedatum: 2020-05-25
Datum der Annahme: 2019-09-12
Downloads: 55 (2024), 149 (2023), 183 (2022), 158 (2021), 49 (2020)
Lizenz: https://rightsstatements.org/vocab/InC-NC/1.0/
URL naar item: https://archiv.ub.uni-marburg.de/diss/z2019/0501
https://doi.org/10.17192/z2019.0501

Gelijkaardige items